Related Experiment Videos
Sirt1 protects against high-fat diet-induced metabolic damage
Paul T Pfluger1, Daniel Herranz, Susana Velasco-Miguel
1Department of Psychiatry, Obesity Research Center, Genome Research Institute, University of Cincinnati College of Medicine, Cincinnati, OH 45237, USA.
Abstract:
The identification of new pharmacological approaches to effectively prevent, treat, and cure the metabolic syndrome is of crucial importance. Excessive exposure to dietary lipids causes inflammatory responses, deranges the homeostasis of cellular metabolism, and is believed to constitute a key initiator of the metabolic syndrome. Mammalian Sirt1 is a protein deacetylase that has been involved in resveratrol-mediated protection from high-fat diet-induced metabolic damage, but direct proof for the implication of Sirt1 has remained elusive. Here, we report that mice with moderate overexpression of Sirt1 under the control of its natural promoter exhibit fat mass gain similar to wild-type controls when exposed to a high-fat diet. Higher energy expenditure appears to be compensated by a parallel increase in food intake. Interestingly, transgenic Sirt1 mice under a high-fat diet show lower lipid-induced inflammation along with better glucose tolerance, and are almost entirely protected from hepatic steatosis. We present data indicating that such beneficial effects of Sirt1 are due to at least two mechanisms: induction of antioxidant proteins MnSOD and Nrf1, possibly via stimulation of PGC1alpha, and lower activation of proinflammatory cytokines, such as TNFalpha and IL-6, via down-modulation of NFkappaB activity. Together, these results provide direct proof of the protective potential of Sirt1 against the metabolic consequences of chronic exposure to a high-fat diet.
Insights
Sirtuin 1 (SIRT1) overexpression in mice protects against high-fat diet-induced metabolic damage. This study provides direct evidence that SIRT1 mitigates inflammation and improves glucose tolerance, offering potential therapeutic strategies for metabolic syndrome.
Area of Science:
- Metabolic Syndrome Research
- Molecular Biology
- Nutritional Science
Background:
- Metabolic syndrome is a critical health concern, with dietary lipids initiating inflammatory responses and metabolic derangement.
- Mammalian Sirtuin 1 (SIRT1) is implicated in resveratrol's protective effects against high-fat diet damage, but direct evidence was lacking.
Purpose of the Study:
- To provide direct proof of Sirtuin 1's (SIRT1) role in protecting against metabolic syndrome.
- To investigate the mechanisms underlying SIRT1's protective effects against high-fat diet-induced damage.
Main Methods:
- Generation of transgenic mice with moderate overexpression of Sirtuin 1 (SIRT1) under its natural promoter.
- Exposure of wild-type and transgenic mice to a high-fat diet.
- Assessment of metabolic parameters, including fat mass, energy expenditure, food intake, glucose tolerance, hepatic steatosis, and inflammatory markers.
Main Results:
- Transgenic SIRT1 mice showed similar fat mass gain but increased energy expenditure and food intake compared to controls on a high-fat diet.
- SIRT1 overexpression significantly reduced lipid-induced inflammation, improved glucose tolerance, and nearly eliminated hepatic steatosis.
- Mechanisms involved induction of antioxidant proteins (MnSOD, Nrf1) via PGC1alpha and down-regulation of pro-inflammatory cytokines (TNFα, IL-6) via NFκB.
Conclusions:
- This study provides direct evidence for the protective role of Sirtuin 1 (SIRT1) against the metabolic consequences of chronic high-fat diet exposure.
- SIRT1 activation offers a promising therapeutic target for preventing and treating metabolic syndrome and related conditions.
